These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2559800)

  • 1. Mitotic abnormalities leading to cancer predisposition and progression.
    Cavenee WK
    Cancer Detect Prev; 1989; 14(2):269-73. PubMed ID: 2559800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor progression stage: specific losses of heterozygosity.
    Cavenee WK
    Princess Takamatsu Symp; 1989; 20():33-42. PubMed ID: 2488236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of human cancer predisposition and progression.
    Cavenee WK; Scrable HJ; James CD
    Mutat Res; 1991 Apr; 247(2):199-202. PubMed ID: 2011137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of genetic defects during astrocytoma progression.
    Cavenee WK
    Cancer; 1992 Sep; 70(6 Suppl):1788-93. PubMed ID: 1325281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
    Kasai Y; Takeda S; Takagi H
    Semin Surg Oncol; 1996; 12(3):155-9. PubMed ID: 8727603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
    Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
    Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.
    Poon TC; Wong N; Lai PB; Rattray M; Johnson PJ; Sung JJ
    Gastroenterology; 2006 Oct; 131(4):1262-70. PubMed ID: 17030195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor suppressor genes].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1265-73. PubMed ID: 8392829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
    Leung TH; Wong N; Lai PB; Chan A; To KF; Liew CT; Lau WY; Johnson PJ
    Mod Pathol; 2002 Nov; 15(11):1213-20. PubMed ID: 12429801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization.
    Guan XY; Fang Y; Sham JS; Kwong DL; Zhang Y; Liang Q; Li H; Zhou H; Trent JM
    Genes Chromosomes Cancer; 2000 Oct; 29(2):110-6. PubMed ID: 10959090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
    Peng SY; Ou YH; Chen WJ; Li HY; Liu SH; Pan HW; Lai PL; Jeng YM; Chen DC; Hsu HC
    Int J Oncol; 2005 Apr; 26(4):1053-61. PubMed ID: 15754002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci.
    Su WH; Chao CC; Yeh SH; Chen DS; Chen PJ; Jou YS
    Nucleic Acids Res; 2007 Jan; 35(Database issue):D727-31. PubMed ID: 17098932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic events unmask recessive cancer genes to initiate malignancy.
    Gallie BL; Worton RG
    J Cell Biochem; 1986; 32(3):215-22. PubMed ID: 3023409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization.
    Marchio A; Meddeb M; Pineau P; Danglot G; Tiollais P; Bernheim A; Dejean A
    Genes Chromosomes Cancer; 1997 Jan; 18(1):59-65. PubMed ID: 8993981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal genomic alterations in glioma malignancy stages.
    James CD; Carlbom E; Dumanski JP; Hansen M; Nordenskjold M; Collins VP; Cavenee WK
    Cancer Res; 1988 Oct; 48(19):5546-51. PubMed ID: 2901288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.